Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Milgamma, containing benfotiamine and pyridoxine, is used to address disorders related to vitamin B1 and B6 deficiency and peripheral nerve dysfunction.

• Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory deficits associated with long‑term diabetes.
• Peripheral nerve disorders: supports nerve health and may improve symptoms in various neuropathic conditions.
• Vitamin B1 deficiency: restores thiamine levels, aiding carbohydrate metabolism.
• Vitamin B6 deficiency: replenishes pyridoxine, facilitating amino‑acid metabolism and neurotransmitter synthesis.

• Benfotiamine is a lipid‑soluble pro‑drug of thiamine that readily crosses cell membranes and is converted to thiamine diphosphate, the active cofactor for enzymes of the pentose phosphate pathway, thereby enhancing glucose metabolism and limiting formation of advanced glycation end‑products. Pyridoxine hydrochloride provides vitamin B6, a cofactor for transamination, decarboxylation and neurotransmitter synthesis, supporting neuronal function.

Milgamma may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild stomach upset reported by some users.
• Headache: transient headache episodes.
• Gastrointestinal discomfort: occasional abdominal pain or dyspepsia.
• Skin rash: mild erythema or itching.

Serious or Rare Side Effects

• Hypersensitivity reaction: signs of anaphylaxis such as swelling, difficulty breathing.
• Severe skin eruption: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hematologic changes: rare cases of leukopenia or thrombocytopenia.
• Liver enzyme elevation: uncommon increase in hepatic transaminases.

When considering Milgamma, several precautions should be observed to ensure safe use.

• Pregnancy: safety has not been established; use only if potential benefit justifies risk.
• Breastfeeding: caution advised as excretion in milk is unknown.
• Renal impairment: monitor renal function, dose may need adjustment.
• Drug hypersensitivity: avoid if known allergy to benfotiamine or pyridoxine.
• Concomitant medications: review for potential interactions with anticoagulants or antiepileptics.
• Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Milgamma can interact with certain medicines, affecting either its efficacy or the co‑administered drug.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): high doses of vitamin B6 may potentiate anticoagulant effect.
• Antiepileptic drugs (e.g., phenytoin): pyridoxine may reduce seizure control.

Moderate Interactions (Monitor Closely)

• Diuretics: may increase urinary loss of B vitamins.
• Metformin: potential additive effect on glucose metabolism.
• Chemotherapeutic agents: high‑dose B vitamins could interfere with certain cytotoxic mechanisms.